* Based on the trial product estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies ** Based on the treatment policy estimand: estimated efficacy regardless of whether patients stayed on treatment or took other weight loss therapies About CagriSema CagriSema is being investigated by Novo Nordisk as a once-weekly subcutaneous injectable treatment for adults with overweight or obesity (REDEFINE program) and as a treatment for adults with type 2 diabetes (REIMAGINE program)
In one study, Lee, Cell Metabolism demonstrated that MOTS-c improved insulin resistance and protected against diet-induced obesity in mice
Third-party laboratory testing represents the gold standard for quality verification
There has not been a UL (upper intake level) established for B12 because it is not stored in your body and therefore, can not build up enough to cause serious adverse side effects for most people
Some of these include: Nausea Increased urination Urinary tract infections (UTIs) Upper respiratory infections Genital yeast infections They both also share some rare, more serious side effects, including: Allergic reactions (hives, swelling of your face, tongue, and throat, and trouble breathing) Low blood sugar (hypoglycemia) Dehydration and low blood pressure (if you are over 65 years of age, have kidney problems, or are taking diuretics, youre more likely to have this problem) Severe UTIs Farxiga can also rarely cause necrotizing fasciitis, a severe skin infection in your genital area
